Get started
Author

Samuel Osagie

Observed name: Osagie, Samuel
Institution: University of Abuja
ORCID: 0000-0001-8822-5164
Observed ORCID: 0000-0001-8822-5164
OpenAlex ID: A5066068965
Hypertension Treatment in Nigeria (HTN) Program: rationale and design for a type 2 hybrid, effectiveness, and implementation interrupted time series trial
2022 · Abigail S. Baldridge, Kasarachi Aluka-Omitiran, et al. · Implementation Science Communications · 40
PDF
Sodium Content and Labelling of Packaged Foods and Beverages in Nigeria: A Cross-Sectional Study
2022 · Adedayo E. Ojo, Alexandra Jones, et al. · Nutrients · 12
PDF
Study design and protocol of a stepped wedge cluster randomized trial using a practical implementation strategy as a model for hypertension-HIV integration — the MAP-IT trial
2023 · Angela A. Aifah, Erinn M. Hade, et al. · Implementation Science · 11
PDF
Establishing a database for sickle cell disease patient mapping and survival tracking: The sickle pan-african research consortium Nigeria example
2022 · Obiageli Nnodu, Anazoeze Madu, et al. · Frontiers in Genetics · 11
PDF
Enhancing hypertension education of community health extension workers in Nigeria’s federal capital territory: the impact of the extension for community healthcare outcomes model on primary care, a quasi-experimental study
2024 · Abigail S. Baldridge, Ikechukwu A. Orji, et al. · BMC Family Practice · 8
PDF
Supportive supervision visits in a large community hypertension programme in Nigeria: implementation methods and outcomes
2025 · Gabriel Lamkur Shedul, Nanna Ripiye, et al. · BMJ Open Quality · 7
PDF
Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial
2025 · Jiancheng Ye, Lisa R. Hirschhorn, et al. · Implementation Science · 6
Early stakeholder engagement lessons from managing hypertension among people living with human-immunodeficiency virus: an integrated model (MAP-IT)
2022 · Dike Ojji, Angela Aifah, et al. · European Heart Journal · 3
PDF
Effects of a Pragmatic Type 2 Hybrid Interrupted Time Series Trial on Hypertension Treatment and Control in Nigeria
2024 · Dike Ojji, Abigail S. Baldridge, et al. · Research Square · 2
Hypertension Treatment in Nigeria (HTN) Program Rationale and Design for a Type 2 Hybrid, Effectiveness, and Implementation Interrupted Time Series Trial
2022 · Abigail Baldridge, Kasarachi Aluka-Omitiran, et al. · Research Square · 2
PDF
Managing Hypertension Among People Living With Hiv: an Integrated Model Trial
2026 · Dike Ojji, Angela Aifah, et al. · Journal of Hypertension
Additional file 1 of Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial
2026 · Ye, Jiancheng, Hirschhorn, Lisa R., et al. · Figshare
Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial
2026 · Ye, Jiancheng, Hirschhorn, Lisa R., et al. · Figshare
Managing Hypertension Among People Living With HIV: A Stepped-Wedge Cluster Randomized Trial of an Integrated Model in Nigeria
2026 · Dike Ojji, Angela A. Aifah, et al. · SSRN Electronic Journal
Impact evaluation of the Hypertension Treatment in Nigeria program using the Translational Science Benefits Model
2026 · Guhan Iyer, Nanna Ripiye, et al. · Journal of Clinical and Translational Science
PDF
Design and implementation of a drug revolving fund for hypertension treatment in primary care setting of the Federal Capital Territory, Nigeria
2025 · Grace Julcit Shedul, Eugenia N Ugwuneji, et al. · BMJ Global Health
PDF
Integrating non-communicable diseases awareness campaign into periodic human immunodeficiency virus awareness campaign: lessons from events of World AIDS Day in Akwa Ibom State, Nigeria
2025 · Daniel Henry, Anyiekere Ekanem, et al. · European Heart Journal
PDF
Works count: 27
Citation count: 102
H-index: 6
I10-index: 4
Year
Topic
Type